Trials / Unknown
UnknownNCT01763593
Safety and Surgical Performance Study of Aurosleek Surgical Blades
A Prospective, Open Label, Observational Study To Evaluate The Safety And Surgical Performance Of Surgical Blade (Aurosleek) In Cataract Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (estimated)
- Sponsor
- Aurolab · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and surgical effectiveness of surgical blades (Aurosleek) made by Aurolab.
Detailed description
Cataract till today remains the most common yet treatable cause of blindness accounting for more than 50% of blindness and visual impairment in the developing world. One of the most important features of a blade for cataract surgery is its predictable and repeatable behavior. The surgeon repeatedly and reliably needs to create similar tunnels of the proper length. Aurolab is producing surgical blades (Aurosleek) intended for making incision in cataract surgeries.
Conditions
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-05-01
- Completion
- 2013-06-01
- First posted
- 2013-01-09
- Last updated
- 2013-04-30
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01763593. Inclusion in this directory is not an endorsement.